Related Experiment Video
Updated: May 18, 2026

04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Small hepatocellular carcinomas and thrombocytopenia
Brian I Carr1, Vito Guerra, Massimo De Giorgio
1Department of Nutritional Carcinogenesis, IRCCS de Bellis, National Institute for Digestive Diseases, Castellana Grotte, Italy. brianicarr @ hotmail.com
Oncology
|September 26, 2012
Summary
Hepatocellular carcinoma (HCC) presentation differs by tumor size. Smaller HCCs often show thrombocytopenia and elevated bilirubin, while larger ones present with normal platelets and bilirubin, indicating distinct clinical patterns.
Area of Science:
- Hepatology
- Oncology
- Radiology
Background:
- Clinical phenotypes of small and large hepatocellular carcinomas (HCCs) require further characterization.
- Screening plays a crucial role in early HCC detection.
Purpose of the Study:
- To evaluate the distinct clinical and radiological characteristics of small HCCs identified through screening.
- To compare HCCs ≤3 cm versus >3 cm in maximum tumor diameter.
Main Methods:
- A cohort of 430 HCCs diagnosed via screening was analyzed.
- Tumors were dichotomized into ≤3 cm and >3 cm groups.
- Radiological and blood test parameters were compared between groups.
Main Results:
- Females were more likely to have smaller tumors.
- Larger tumors (>3 cm) showed higher rates of portal vein thrombosis (PVT) (15% vs 5%).
- Smaller tumors were associated with thrombocytopenia, elevated alpha-fetoprotein (AFP), and bilirubin levels.
Conclusions:
- Two distinct patterns of HCC presentation exist based on tumor size.
- Smaller HCCs are linked to thrombocytopenia and elevated bilirubin, suggesting a different biological behavior or progression.
- Larger HCCs are associated with normal platelet and bilirubin levels, potentially indicating a slower-growing or less aggressive phenotype at diagnosis.
More Related Videos
Related Concept Videos
Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

